Devasis Chatterjee Selected Research

Devasis Chatterjee Research Topics

Disease

12	Neoplasms (Cancer) 01/2015 - 01/2004
6	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 08/2004
6	Neoplasm Metastasis (Metastasis) 01/2014 - 10/2007
2	Adenocarcinoma 01/2014 - 05/2008
2	Breast Neoplasms (Breast Cancer) 01/2014 - 01/2013
2	Stomach Neoplasms (Stomach Cancer) 01/2014 - 01/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2015
1	Colonic Neoplasms (Colon Cancer) 10/2013
1	Carcinoma (Carcinomatosis) 10/2013
1	Melanoma (Melanoma, Malignant) 12/2012
1	Lung Neoplasms (Lung Cancer) 06/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2004

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2015 - 10/2007
5	Phosphatidylethanolamine Binding ProteinIBA 01/2014 - 10/2007
3	CytokinesIBA 01/2015 - 01/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 04/2004
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2014 - 05/2008
3	CamptothecinIBA 10/2013 - 08/2004
3	raf KinasesIBA 01/2013 - 05/2008
2	Messenger RNA (mRNA)IBA 01/2015 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 10/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2014 - 10/2013
2	Proto-Oncogene Proteins c-rafIBA 01/2013 - 10/2007
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2012 - 05/2008
2	AntibodiesIBA 11/2010 - 01/2004
2	NF-kappa B (NF-kB)IBA 09/2008 - 10/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	2- methoxyoestra- 1,3,5(10),16- tetraene- 3- carboxamideIBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2013
1	AgarIBA 10/2013
1	ProhibitinsIBA 10/2013
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2013
1	Phenobarbital (Luminal)FDA Link 01/2013
1	Estrogens (Estrogen)FDA Link 01/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2013
1	ClaudinsIBA 01/2013
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 12/2012
1	SynteninsIBA 12/2012
1	Indicators and Reagents (Reagents)IBA 06/2011
1	Conditioned Culture MediaIBA 11/2010
1	2,2'- (hydroxynitrosohydrazono)bis- ethanamineIBA 09/2008
1	Nitric Oxide DonorsIBA 09/2008
1	Transcription Factors (Transcription Factor)IBA 05/2008
1	Death Domain ReceptorsIBA 10/2007
1	LigandsIBA 10/2007
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 10/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2007
1	Oncostatin MIBA 01/2005
1	Rituximab (Mabthera)FDA Link 10/2004
1	taurolidineIBA 09/2004
1	Antineoplastic Agents (Antineoplastics)IBA 09/2004
1	Small Interfering RNA (siRNA)IBA 04/2004
1	Oncogene Proteins (Oncogene Protein)IBA 04/2004

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2015 - 09/2008
3	Therapeutics 01/2015 - 01/2004
2	Aftercare (After-Treatment) 10/2013 - 04/2004
2	Immunotherapy 09/2008 - 01/2004